Cite
HARVARD Citation
Baddley, J. et al. (2018). ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents). Clinical microbiology and infection. pp. S10-S20. [Online].